Related Experiment Video
Updated: Dec 24, 2025
09:43
Mouse Model of Middle Cerebral Artery Occlusion
Published on: February 13, 2011
79.2K
The European Research Network on Signal Transduction (ERNEST): Toward a Multidimensional Holistic Understanding of G
Martha E Sommer1,2, Jana Selent3, Jens Carlsson4
1Institute of Medical Physics and Biophysics, Charité-Universitätsmedizin Berlin, Berlin, 10117, Germany.
ACS Pharmacology & Translational Science
|April 17, 2020
Summary
Two research consortia, GLISTEN and ERNEST, advanced the study of G protein-coupled receptors (GPCRs) and their signaling pathways. Their work aims to improve drug design by mapping complex cellular communication for better therapeutic targeting.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- G protein-coupled receptors (GPCRs) are crucial transmembrane proteins involved in cellular signal transduction.
- GPCRs are significant therapeutic targets due to their roles in human physiology and disease.
Purpose of the Study:
- To advance the development of molecular modulators for GPCR function.
- To broaden the focus to entire signaling cascades for a more holistic understanding of signal transduction.
Main Methods:
- Establishment and activities of the GLISTEN (COST Action CM1207) and ERNEST (COST Action CA18133) research consortia.
- Integration of diverse data and perspectives on GPCR structure, dynamics, and signaling.
Main Results:
- Significant growth in knowledge of GPCR structure and dynamics.
- Expansion of research focus from individual receptors to entire signaling cascades.
- Development of a framework for a multidimensional map of GPCR signaling.
Conclusions:
- A holistic approach to GPCR signaling complexity enhances drug design.
- Improved therapeutic targeting strategies can be developed through integrated research.
- The consortia facilitate collaborative advancements in GPCR-targeted therapeutics.